Bayesian Capital Management, LP Silk Road Medical Inc Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$11.38 - $19.03 $154,893 - $259,017
13,611 New
13,611 $249,000
Q4 2022

Feb 14, 2023
BUY
$40.54 - $56.2 $374,022 - $518,501
9,226 New
9,226 $487,000
Q2 2021

Aug 13, 2021
SELL
$44.66 - $63.06 $303,688 - $428,808
-6,800 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$46.31 - $62.7 $314,908 - $426,360
6,800 New
6,800 $344,000

Others Institutions Holding SILK

# of Institutions
5
Shares Held
3.48M
Call Options Held
19.8K
Put Options Held
0
View Full List

About Silk Road Medical Inc

SILK Quotes by TradingView
  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email